Terns Pharmaceuticals Inc (TERN) USD0.0001
1.26%- This stock can be held in a
Stocks and Shares ISASell:$2.91
Buy:$2.92
Change:
$0.13
(4.26%)
$0.13
(4.26%)Market closed | Prices delayed by at least 15 minutes
Sell:$2.91
Buy:$2.92
Change:$0.13
(4.26%)
$0.13
(4.26%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 1 April 2025 | Emil T. KuriakoseOther Level A | Sell Regular sell transaction (market) | 952 | $2.49 | $2,365.82 | 53,317 |
| 6 January 2025 | Mark J VignolaCFO | Sell Option/Award related | 9,059 | $5.80 | $52,499.62 | 74,752 |
| 6 January 2025 | Jill M QuigleyDirector | Sell Option/Award related | 8,760 | $5.79 | $50,758.07 | 0 |
| 2 January 2025 | Mark J VignolaCFO | Sell Tax related | 8,129 | $5.72 | $46,523.89 | 83,811 |
| 2 January 2025 | Emil T. KuriakoseOther Level A | Sell Tax related | 4,481 | $5.71 | $25,607.12 | 54,269 |
| 2 January 2025 | Jill M QuigleyDirector | Sell Tax related | 6,240 | $5.72 | $35,702.16 | 8,760 |
| 5 December 2024 | Amy Louise BurroughsCEO | Buy Regular purchase transaction | 15,450 | $7.15 | $110,467.50 | 19,099 |
| 30 November 2024 | Amy Louise BurroughsCEO | Buy Regular purchase transaction | 510 | $5.11 | $2,606.10 | 19,609 |
| 30 November 2024 | Sun (Melita) JungChief Level Officer | Buy Regular purchase transaction | 2,250 | $5.11 | $11,497.50 | 2,250 |
| 12 September 2024 | NEXTBIO CAPITAL LLCVenture Capital | Buy Regular purchase transaction | 285,714 | $10.50 | $2,999,997.00 | 476,190 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 12 September 2024 | NEXTBIO CAPITAL LLCVenture Capital | Buy Regular purchase transaction | 285,714 | $10.50 | $2,999,997.00 | 476,190 |
| 12 September 2024 | NEXTBIO CAPITAL LLCVenture Capital | Buy Regular purchase transaction | 190,476 | $10.50 | $1,999,998.00 | 190,476 |
| 15 July 2024 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 39,433 | $10.00 | $394,330.00 | 4,843,421 |
| 9 September 2024 | Jill M QuigleyDirector | Sell Option/Award related | 17,235 | $10.00 | $172,350.00 | 15,000 |
| 15 July 2024 | Jill M QuigleyDirector | Sell Option/Award related | 14,365 | $10.00 | $143,660.06 | 30,000 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.